Literature DB >> 1375653

Influence of codon context on UGA suppression and readthrough.

J Kopelowitz1, C Hampe, R Goldman, M Reches, H Engelberg-Kulka.   

Abstract

We studied the influence of the codon context on UGA suppression by a suppressor tRNA and on UGA readthrough by a normal tRNA in Escherichia coli. This was done by a series of constructs where only the immediate context of the TGA codon was varied by only one nucleotide at a time. For both UGA suppression and UGA readthrough the codon context had a similar influence according to the following rules. (1) The nature of the nucleotide immediately adjacent to the 3' side of the UGA is an important determinant; at that position the level of UGA translation is influenced by the nucleotides in the order A greater than G greater than C greater than U. (2) At extremely high or low levels of UGA translation this influence of the adjacent 3' nucleotide is not seen. (3) In all cases, the nature of both the nucleotide immediately adjacent to the 5' side of the codon and that following the base adjacent to the 3' side of the codon have little effect, if any, on UGA translation. The varying influence of the codon context effect on UGA translation is discussed in relation to its role in gene expression.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1375653     DOI: 10.1016/0022-2836(92)90920-f

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  38 in total

1.  Imbalance of tRNA(Pro) isoacceptors induces +1 frameshifting at near-cognate codons.

Authors:  Michael O'Connor
Journal:  Nucleic Acids Res       Date:  2002-02-01       Impact factor: 16.971

Review 2.  Misreading of termination codons in eukaryotes by natural nonsense suppressor tRNAs.

Authors:  H Beier; M Grimm
Journal:  Nucleic Acids Res       Date:  2001-12-01       Impact factor: 16.971

3.  A dynamic competition between release factor 2 and the tRNA(Sec) decoding UGA at the recoding site of Escherichia coli formate dehydrogenase H.

Authors:  J B Mansell; D Guévremont; E S Poole; W P Tate
Journal:  EMBO J       Date:  2001-12-17       Impact factor: 11.598

4.  Clinical manufacturing of recombinant human interleukin 15. I. Production cell line development and protein expression in E. coli with stop codon optimization.

Authors:  Vinay V Vyas; Dominic Esposito; Terry L Sumpter; Trevor L Broadt; James Hartley; George C Knapp; Wei Cheng; Man-Shiow Jiang; John M Roach; Xiaoyi Yang; Steven L Giardina; George Mitra; Jason L Yovandich; Stephen P Creekmore; Thomas A Waldmann; Jianwei Zhu
Journal:  Biotechnol Prog       Date:  2011-12-09

5.  An orthogonalized platform for genetic code expansion in both bacteria and eukaryotes.

Authors:  James S Italia; Partha Sarathi Addy; Chester J J Wrobel; Lisa A Crawford; Marc J Lajoie; Yunan Zheng; Abhishek Chatterjee
Journal:  Nat Chem Biol       Date:  2017-02-13       Impact factor: 15.040

6.  A bioassay based on recombinant DNA technology for determining selenium concentration.

Authors:  M Reches; C Zhao; H Engelberg-Kulka
Journal:  Appl Environ Microbiol       Date:  1994-01       Impact factor: 4.792

7.  Competition between frameshifting, termination and suppression at the frameshift site in the Escherichia coli release factor-2 mRNA.

Authors:  F M Adamski; B C Donly; W P Tate
Journal:  Nucleic Acids Res       Date:  1993-11-11       Impact factor: 16.971

8.  UGA suppression by tRNACmCATrp occurs in diverse virus RNAs due to a limited influence of the codon context.

Authors:  C Urban; K Zerfass; C Fingerhut; H Beier
Journal:  Nucleic Acids Res       Date:  1996-09-01       Impact factor: 16.971

9.  Relationships between bacterial drug resistance pumps and other transport proteins.

Authors:  J H Parish; J Bentley
Journal:  J Mol Evol       Date:  1996-02       Impact factor: 2.395

10.  Cis control of gene expression in E.coli by ribosome queuing at an inefficient translational stop signal.

Authors:  Haining Jin; Asgeir Björnsson; Leif A Isaksson
Journal:  EMBO J       Date:  2002-08-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.